 |
 |

COMMENTS AND OPINIONS
Evidence Needed for Policy Decisions: Adherence Interventions and Medicare Part D
Daniel R. Touchette, PharmD, MA;
Andrew L. Masica, MD, MSc
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
It was with great interest that we read the article by Kripalani et al1 regarding interventions to enhance medication adherence. As one of the goals of medication therapy management (MTM) programs under the Medicare Modernization Act, the focus on methods of improving adherence has become of paramount importance.2 Medication therapy management is targeted at those most at risk for adherence-related problems, ie, individuals older than 65 years with multiple chronic conditions taking many medications. Despite the knowledge that those with poor adherence have more hospitalizations and higher medical costs, practitioners and insurers in a position to develop programs that have an impact on adherence must do so with little information on what is truly effective.3
In their article, Kripalani et al1 discuss the complex nature of adherence and difficulty in identifying which intervention components were primarily responsible for the observed . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Interventions to Enhance Medication Adherence in Chronic Medical Conditions: A Systematic Review
Sunil Kripalani, Xiaomei Yao, and R. Brian Haynes
Arch Intern Med. 2007;167(6):540-549.
ABSTRACT
| FULL TEXT
|